Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset

CLDN18-ARHGAP26/6 fusions have been identified in gastric cancers, with a predominance in diffuse-type gastric cancers (DGCs). Although in vitro experiments have suggested an oncogenic role for CLDN18-ARHGAP26/6 fusions, the exact frequencies and clinicopathological characteristics of the fusion-pos...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Tanaka, Atsushi, Ishikawa, Shumpei, Ushiku, Tetsuo, Yamazawa, Sho, Katoh, Hiroto, Hayashi, Akimasa, Kunita, Akiko, Fukayama, Masashi
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047683/
https://ncbi.nlm.nih.gov/pubmed/30034621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25464
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires